Among the many departments and verticals which decorate the AI billboards of San Francisco and subway stops in New York - where greenfield often rightfully seems plentiful whichever direction your die is cast, there’s a particular space quietly larger than much of the rest. Though enterprise procurement departments have over the past few decades supported a number of strong software outcomes, the largest opportunities in the market remain overwhelmingly untapped unplucked. Today Pranav Mulgund, Naveen Kashyap, and the rest of the team at Fragment announce their Series A; our good fortune to lead the round reflects our conviction that they will come to define the category - bringing best-in-class technical talent to turn the most languid parts of supply chain work into product that delights procurement professionals.
Today, Anthropic and BigHat Biosciences announced a historic collaboration: a single Anthropic researcher, armed with Claude, operated BigHat’s automated lab to optimize two antibodies. This marks one of the first instances of a frontier AI lab and next-gen bio lab teaming up, and a potential watershed for drug discovery.
Today, Orchestra announced they will join OpenAI to build their life sciences applications.
Most AI thus far has primarily been deployed with an oddly isolationist architecture: one employee, one terminal, and more often than not, one model. Intelligence is consumed individually, augmenting one person at a time. But organizations have never utilized human intelligence this way. They combine people with different abilities, give them shared context, divide work among them, and coordinate the result. The company, not the individual employee, is the unit that produces.
